99 results
6-K
EX-99.1
SNY
Sanofi
28 May 24
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
12:04pm
efforts on leveraging our technology platform and novel adjuvant in research and development and pipeline expansion to help advance our mission
6-K
EX-99.4
SNY
Sanofi
28 May 24
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
12:04pm
research and deployment company. Its mission is to ensure that artificial general intelligence benefits all of humanity.
This partnership was led
6-K
EX-99.2
SNY
Sanofi
2 Feb 24
Approval based on Phase 3 EoE KIDS trial showing a greater proportion of children taking Dupixent achieved histological remission compared to placebo
1:21pm
to Win Strategy. Under his leadership, our finance organization has been modernized into a team that supports our mission and execution of our
6-K
EX-99.5
SNY
Sanofi
20 Dec 23
Current report (foreign)
10:39am
and simplifying treatment delivery. This partnership and our donation of Fexinidazole Winthrop through Foundation S, reflect our mission to provide innovative
6-K
EX-99.1
SNY
Sanofi
27 Oct 23
Sanofi Enters Next Chapter of Play to Win Strategy
11:33am
Investment
Sanofi’s strategic mission is to transform the practice of medicine through breakthrough science that improves people’s lives. To that end
6-K
EX-99.3
4r8p3cd u1
20 Jun 23
Current report (foreign)
10:18am
6-K
EX-99.1
9s2v78
2 Jun 23
Approval of the financial statements for the fiscal year 2022
10:53am
6-K
EX-99.1
yqkqaor3z9
8 Aug 22
Sanofi and Innovent Biologics enter strategic
4:27pm
6-K
EX-99.1
ub4m502d dgu
28 Jul 22
Strong execution in Q2 drives full-year 2022 guidance upgrade and delivers rich R&D news flow in Immunology and Rare Disease
10:12am
6-K
EX-99.2
ee1if5m6
28 Jul 22
Condensed Half-year Consolidated Financial Statements
6:17am
6-K
EX-99.1
hyggx
8 Jul 22
Sanofi Global Health launches nonprofit Impact® brand for 30 medicines in low-income countries
11:01am
6-K
EX-99.2
0eq0mda2
13 Jun 22
FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis
2:56pm
6-K
EX-99.1
r76 z81vgjym3v0z
29 Apr 22
Current report (foreign)
12:38pm
6-K
EX-99.1
13gu 40f1t8j
4 Apr 22
Distribution of Shares of Euroapi
11:21am
6-K
EX-99.1
ik66vjad8in
22 Nov 21
Current report (foreign)
12:42pm
6-K
EX-99.1
0aulr3zhxcweuh6s4bq2
10 Sep 21
Sanofi provides update on Phase 3 study evaluating rilzabrutinib for the treatment of pemphigus
3:23pm
SC TO-T
EX-99
y5q5 0tfvkcq8kj
16 Aug 21
Third party tender offer statement
8:09am
6-K
EX-99.1
lbfwupcat2
30 Jul 21
Current report (foreign)
4:01pm
6-K
EX-99.2
ghesz
29 Jul 21
Current report (foreign)
10:48am